December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Effects of Tenascin-C on the Angiogenic Potential of Retinal Endothelial Cells
Author Affiliations & Notes
  • R Castellon
    Ophthalmology Research Laboratories Cedars-Sinai Medical Center Los Angeles CA
  • S Caballero
    Department of Pharmacology University of Florida Gainesville FL
  • HK Hamdi
    Ophthalmology Research Laboratories Cedars-Sinai Medical Center Los Angeles CA
  • AM Aoki
    Ophthalmology Research Laboratories Cedars-Sinai Medical Center Los Angeles CA
  • MC Kenney
    Ophthalmology Research Laboratories Cedars-Sinai Medical Center Los Angeles CA
  • MB Grant
    Department of Pharmacology University of Florida Gainesville FL
  • AV Ljubimov
    Ophthalmology Research Laboratories Cedars-Sinai Medical Center Los Angeles CA
  • Footnotes
    Commercial Relationships   R. Castellon, None; S. Caballero, None; H.K. Hamdi, None; A.M. Aoki, None; M.C. Kenney, None; M.B. Grant, None; A.V. Ljubimov, None. Grant Identification: Support: NIH Grant EY12605
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 1328. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R Castellon, S Caballero, HK Hamdi, AM Aoki, MC Kenney, MB Grant, AV Ljubimov; Effects of Tenascin-C on the Angiogenic Potential of Retinal Endothelial Cells . Invest. Ophthalmol. Vis. Sci. 2002;43(13):1328.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Tenascin-C (TN-C) is an extracellular matrix protein expressed in embryogenesis and in adult tissues undergoing remodeling and healing. We previously reported that TN-C was upregulated in diabetic retinopathy (DR) human retinas. However, its precise role remained elusive. We hypothesized that TN-C promotes the angiogenic phenotype. Our purpose was to examine TN-C production by retinal endothelial cells (REC) in response to growth factors (GFs) known to be upregulated in DR, as well as the effects of TN-C +/- GFs on various in vitro angiogenic assays. Methods: Bovine and human REC were cultured on plastic and on reconstituted basement membrane matrix (Matrigel). TN-C production, capillary-like tube formation, secondary sprouting, cell migration, survival and proliferation were measured after treatment with combinations of angiogenic growth factors +/- TN-C. The involvement of TN-C integrin receptors on TN-C action was investigated using specific blocking antibodies. Results: TN-C delayed tube collapse of REC on Matrigel in a dose- and time-dependent manner. It also decreased tube collapse induced by serum deprivation, 30 mM glucose and 0.1 nM TGF-ß by 50%, 35% and 85%, with similar effects on REC growing on plastic. This indicates that TN-C exerts some survival effects. TN-C also increased secondary sprouting, REC proliferation, migration and tube branching. αVß3 integrin was important for TN-C action since a blocking antibody to this integrin decreased tube length, network complexity and secondary sprouting by 50%, 35% and 100%. Antibodies against αVß6, αVß5, and α9ß1 integrins had little or no effect. Immunocytochemistry showed that GFs known to be upregulated in DR retinas increased TN-C deposition in an additive or synergistic manner, which may explain why DR cells have higher basal levels of TN-C. Conclusion: TN-C was overexpressed in diabetic and DR REC cultures and was upregulated by GF combinations. TN-C enhanced the angiogenic potential of REC as measured by a variety of in vitro assays. The data suggest that TN-C may act as a pro-angiogenic mediator in DR and other pathological conditions and provide possible avenues for future therapeutic intervention.

Keywords: 566 retinal neovascularization • 423 growth factors/growth factor receptors • 403 extracellular matrix 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×